Mice were injected daily by morphine sulfate for 22 days, then forced to drink morphine solution for 5 days, and finally injected with 0.5 M hydroxylamine hydrochloride intracranially. Forth-eight hours after the injection, they were given the choice between morphine sulfate solution and water. Hydroxylamine-injected animals consumed less morphine solution than two control groups.
morphine dosage was increased by 5 mg, until 30 mg/kg of body weight per day was being injected . This amount was kept constant up to the end of the injection series (22 days altogether).
For the following 5 days , the mice were not injected with morphine , but obtained only a solution of morphine sulfate (0 .5 mg/m!) for drinking.
On the 27th day of the experiment , the morphine solution was replaced again by drinking water , and the groups of animals were injected intracranially with 20 microliters of 0.5 M sodium chloride solution or 20 microliters of 05 M hydroxylamine hydrochloride neutralized with sodium hydroxide to pH 7.35. The injection needle was inserted through the temporal muscle parallel with the surface of the cerebral cortex. Thus , we tried to avoid damage to the brain tissue.
The period of abstinence lasted 2 days, during which water and food consumption, rectal temperature, and body weight were recorded.
After the period of abstinence , the mice were given the choice between the morphine solution and water again . Consumption of water, morphine solution, and food were measured and recorded for another 10 days.
Body weight and food consumption did not change substantially during the series of morphine injections. Body weight temporarily decreased after the intracranial injection of saline or hydroxylamine , but the food consumption reached the original values within 48 h after saline and 4 days after hydroxylamine injections. Comparison with the group of mice that were not injected at all shows that the decrease of body weight may have been caused partly by the intracranial injection, partly by the withdrawal of morphine.
Measuring of rectal temperature during the period of forced morphine drinking did not show any significant decrease or increase. After the morphine withdrawal and injection of hydroxylamine or saline, the rectal temperature temporarily decreased, but returned to normal within 48 h (Tables I and 2 ). All data indicate that the daily injection of 30 mg of morphine sulfate for 22 days produced some degree of morphine dependence. However, the withdrawal symptoms resembled the consequences of the intracranial injections and were hard to evaluate.
Nevertheless, the whole procedure , morphine injections and food morphine drinking, caused an increase in the drinking of morphine solution. In a free choice situation, the mice drank, on average, significantly more morphine solution after the series of morphine injections than they had before it (see Tables 3 and 4) . At the beginning of the experiment, the mice consumed only, on average, 0.30 ml morphine solution per animal and day (3.8% of their total fluid consumption, 8.1 rnI). After the series of morphine injections, the amount of morphine solution increased both in absolute values and in percentage of the total fluid consumption. Animals injected intracranially with hydroxylamine consumed substantially less morphine than did the saline-injected ones or those without any injection. The results were evaluated by chi-square test. The differences between hydroxylamine-injected animals and their own consumption before the forced morphine drinking are not significant, whereas animals injected with saline or not injected at all drank significantly more morphine solution, p usually being .01 .
Hydroxylamine did not block the behavioral expression of drug dependence completely. The hydroxylamine-treated mice consumed about twice as much morphine as the nonaddicted mice.
Our experiments indicate that intracranial injection of hydroxylamine interferes with the behavioral response of the animals to morphine. We are still unable to explain the biochemical mechanisms of this effect. A hypothesis was formulated earlier, attributing the effect of a potent antimetabolite hydroxylamine to its action on activated DNA (Reinis, 1970) . Development of the drug tolerance and dependence is probably one of the metabolic adaptation phenomena associated with the activation of new parts of the genome. Hydroxylamine may react with this active DNA, change its transcription and translation and thus interfere with the metabolic ada pta tion. Our experiments are comparable with those of Cohen et al (1965) , Yamamoto et al (1967) , Smith et al (1966) , Way et al (1968 ), Feinberg & Cochin (1969 , and Loh et al (1969) , which demonstrated that the development of morphine tolerance and dependence may be blocked by actinomycin D, puromycin, cycloheximide, etc. The main difference between their observations and ours is that we blocked the developed existing dependence ex post. Other substances with similar effect, but without several toxic effects of hyrodxylamine, may be found which may be useful tools in the treatment of drug dependence and tolerance.
